Evaluation of the Use of Antiseptic Nose For Decolonization of Resistant Bacteria in Hospitals

Not Applicable

Recruiting

• Conditions: Human patients infected; Methicillin-resistant Staphylococcus aureus.; B03.300.390.400.800.750.100.500

• Registration Number: RBR-6gs2jh
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-04-24
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients admitted in the Hospital das Clinicas, Ribeirão Preto Medical School, University of Sao Paulo; age over 18 years; isolation of methicillin-resistant Staphylococcus aureus.

Exclusion Criteria

Volunteers carry cystic fibrosis; patients with chronic osteomyelitis; carry infection related to foreign body; topic pregnancy with a live fetus; negative nasal swab for methicillin-resistant Staphylococcus aureus.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference between the number of patients decolonized by Methicillin-resistant Staphylococcus aureus after decolonization therapy in the experimental group with silver sulfadiazine and placebo group. The evaluation of nasal decolonization be performed by culturing for MRSA nasal swabs.

Secondary Outcome Measures

Name	Time	Method
Difference between the number of patients infected by Methicillin-resistant Staphylococcus aureus after decolonization therapy in the experimental group with silver sulfadiazine and placebo group. The evaluation of the incidence of infection will be performed by the Hospital Infection Control Committee.